Infectious Disease

Medical Treatment and Long-Term Care Strategies

At a Glance

Mycetoma treatment usually lasts at least 12 months. Bacterial infections are treated mainly with prolonged antibiotics, while fungal infections often need itraconazole plus surgery; regular testing helps detect medication toxicity and guide safe, effective care.

Treating mycetoma is a long-term process, not a sprint. Because the organisms that cause this infection grow slowly and hide deep within your tissues, treatment often lasts for many months or longer than a year ^[1]^[2]. The strategy your specialist chooses depends on whether your infection is caused by bacteria (actinomycetoma) or fungi (eumycetoma), as well as your overall health, comorbidities, and the disease extent ^[1]^[3].

Medical Strategy for Bacterial Mycetoma (Actinomycetoma)

Bacterial mycetoma is primarily treated with a combination of antibiotics. In many cases, medicine alone is enough to cure the infection, and surgery is rarely needed ^[1]^[4].

Primary Medications: A commonly used treatment involves trimethoprim-sulfamethoxazole (also known as co-trimoxazole) ^[1]. Depending on how severe the infection is and local guidelines, your doctor may also add other antibiotics like amikacin, streptomycin, or amoxicillin-clavulanate ^[1]^[5].
Duration: You should often expect to be on these medications for 12 months or more, though the exact duration is individualized ^[1]^[6].
Effectiveness: Cure rates for bacterial mycetoma are generally very favorable, with some small studies reporting high success rates, although outcomes depend heavily on the individual case and completion of therapy ^[5].

Medical Strategy for Fungal Mycetoma (Eumycetoma)

Fungal mycetoma is more difficult to treat with medicine alone. The most effective approach usually involves a combination of long-term antifungal medicine and surgery to remove the infected mass ^[3]^[2].

Primary Medication: Itraconazole is a standard antifungal drug for eumycetoma ^[2]^[3]. It is typically taken twice a day, though dosing varies ^[2].
The Role of Surgery: Because antifungals often cannot reach the center of a large fungal mass, surgery is usually considered after a period of medication has helped shrink the lesion ^[2]^[7].
Duration: Treatment for fungal mycetoma usually lasts at least 12 months, and often longer ^[2].
Newer Options: A newer drug called fosravuconazole (taken once a week) has been studied, but clinical trials have not shown it to be more effective than daily itraconazole, and it is not an established routine option everywhere ^[2].

Monitoring Your Health During Treatment

Taking strong medications for a year or more requires careful supervision. Your doctor will schedule regular check-ups and tests to ensure the medicine is working and that your body is handling it well. Note that not every patient will need every test, but common monitoring includes:

What is Monitored	Why it Matters	Medications of Concern
Liver Function	Long-term antifungals and some antibiotics can stress the liver ^[8]. Seek care for jaundice, severe nausea, or dark urine.	Itraconazole, Voriconazole ^[9]
Kidney Function	Certain injectable antibiotics can affect how your kidneys filter waste ^[10]. Seek care for markedly reduced urine.	Amikacin, Streptomycin ^[10]
Hearing Tests	Some “aminoglycoside” antibiotics can cause permanent hearing loss or balance issues ^[11].	Amikacin, Streptomycin ^[11]
Drug Levels	Testing your blood to see if you have enough medicine to kill the infection but not so much that it’s toxic ^[12].	Itraconazole, Voriconazole ^[13]
Potassium & BP	Itraconazole can sometimes cause low potassium or high blood pressure ^[14].	Itraconazole ^[14]

Important Safety Warning: Itraconazole has important drug interactions and can have a negative effect on the heart, potentially worsening or precipitating heart failure. Seek urgent care if you develop sudden shortness of breath, severe leg swelling, or palpitations. Co-trimoxazole can cause serious skin rashes; seek care for any severe, spreading rash. Always discuss any pregnancy or breastfeeding considerations, as well as all other medicines and supplements you take.

Treatment Adherence and Adjustments

Do not stop or change your treatment without contacting your treating team ^[15]. Because the swelling and drainage often improve within the first few months, you might feel better before the disease is fully controlled ^[7]. While stopping early can contribute to treatment failure, recurrence can also reflect advanced tissue or bone involvement, residual disease, or resistance ^[16]. Follow-up involves clinical assessment and, when indicated, imaging ^[17]. If side effects, medication costs, or travel barriers are making it hard to stick to the plan, discuss these with your clinic so they can help adjust your care.

Common questions in this guide

How long does mycetoma treatment usually take?

Treatment for mycetoma often lasts 12 months or longer. Bacterial mycetoma may need about a year or more of antibiotics, while fungal mycetoma usually requires at least a year of antifungal treatment and may take longer.

What medicines treat bacterial mycetoma?

Bacterial mycetoma, also called actinomycetoma, is usually treated with a combination of antibiotics. Trimethoprim-sulfamethoxazole is commonly used, and a clinician may add amikacin, streptomycin, or amoxicillin-clavulanate depending on severity and local guidance.

Does fungal mycetoma require surgery?

Fungal mycetoma, or eumycetoma, is often treated with itraconazole plus surgery to remove the infected mass. Antifungal medicine may be given first to shrink the lesion because medicine may not reach the center of a large mass.

What tests are needed during mycetoma treatment?

Monitoring depends on the medicines you take and may include liver and kidney blood tests, hearing checks, drug-level testing, potassium checks, and blood-pressure measurements. These tests help identify medication toxicity and confirm that drug exposure is adequate.

Should I stop mycetoma medicine when swelling improves?

No, do not stop or change treatment without speaking with your treating team. Swelling and drainage can improve before the infection is fully controlled, and stopping early can lead to treatment failure or recurrence.

What side effects require urgent help during mycetoma treatment?

Seek urgent care for sudden shortness of breath, severe leg swelling, or palpitations while taking itraconazole, or for a severe spreading rash with co-trimoxazole. Yellowing of the eyes, dark urine, markedly reduced urine, or new hearing or balance problems should also be reported promptly.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Mycetoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Have you confirmed whether my infection is bacterial (actinomycetoma) or fungal (eumycetoma), and which specific medications will be used?
2.How long do you expect my treatment to last, and what signs of improvement should I look for in the first few months?
3.What is the schedule for monitoring my liver and kidney function while I am on these medications?
4.If I am prescribed amikacin or streptomycin, how will we monitor my hearing and kidney health?
5.How often will we check my drug levels (for example, itraconazole) to ensure the dose is correct for me?
6.If I miss a dose or experience a side effect, what is the best way to report this to the care team?

References (17)

1
[Mycetoma and their treatment].
Develoux M
Journal de mycologie medicale 2016; (26(2)):77-85 doi:10.1016/j.mycmed.2016.03.005.
PMID: 27260344
2
Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial.
Fahal AH, Ahmed ES, Bakhiet SM, et al.
The Lancet. Infectious diseases 2024; (24(11)):1254-1265 doi:10.1016/S1473-3099(24)00404-3.
PMID: 39098321
3
[Eumycetoma due to Fusarium chlamydosporum : Case report und review of the literature].
Malisiewicz B, Uhrlaß S, Nenoff P, Schöfer H
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(8)):612-617 doi:10.1007/s00105-019-4430-8.
PMID: 31289888
4
Treatment of Madura foot: a systematic review.
Salim AO, Mwita CC, Gwer S
JBI database of systematic reviews and implementation reports 2018; (16(7)):1519-1536 doi:10.11124/JBISRIR-2017-003433.
PMID: 29995713
5
Clinical characteristics and treatment of actinomycetoma in northeast Mexico: A case series.
Cárdenas-de la Garza JA, Welsh O, Cuéllar-Barboza A, et al.
PLoS neglected tropical diseases 2020; (14(2)):e0008123 doi:10.1371/journal.pntd.0008123.
PMID: 32097417
6
Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities.
Bonifaz A, Tirado-Sánchez A, Vázquez-González D, et al.
The Journal of dermatological treatment 2022; (33(2)):954-958 doi:10.1080/09546634.2020.1793887.
PMID: 32643472
7
Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
Khatri ML, Al Kubati SAS, Gaffer IA, Majeed SMA
Indian journal of dermatology, venereology and leprology 2022; (88(5)):615-622.
PMID: 35389029
8
The safety of oral antifungals for the treatment of onychomycosis.
Gupta AK, Haas-Neill S, Talukder M
Expert opinion on drug safety 2023; (22(12)):1169-1178 doi:10.1080/14740338.2023.2280137.
PMID: 37925672
9
Antifungal agents and liver toxicity: a complex interaction.
Tverdek FP, Kofteridis D, Kontoyiannis DP
Expert review of anti-infective therapy 2016; (14(8)):765-76 doi:10.1080/14787210.2016.1199272.
PMID: 27275514
10
Linezolid: a safer and effective substitute to aminoglycoside in the treatment of actinomycetoma by Nocardia species.
Chhabra N, Sri P, Ganguly S
International journal of dermatology 2023; (62(9)):1160-1163 doi:10.1111/ijd.16764.
PMID: 37366290
11
Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm.
Deo K, Garg P, Masare A, Deokar SV
BMJ case reports 2024; (17(4)) doi:10.1136/bcr-2023-258686.
PMID: 38663898
12
Precision dosing of systemic antifungals in adults: therapeutic drug monitoring, empiric dose optimization and barriers to implementation.
Chastain DB, Anderson DT, Eudy J, et al.
The Journal of antimicrobial chemotherapy 2026; (81(3)) doi:10.1093/jac/dkag055.
PMID: 41700714
13
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021.
Chau MM, Daveson K, Alffenaar JC, et al.
Internal medicine journal 2021; (51 Suppl 7()):37-66 doi:10.1111/imj.15587.
PMID: 34937141
14
Pseudohyperaldosteroism during itraconazole treatment: a hitherto neglected clinically significant side effect.
Brandi SL, Feltoft CL, Serup J, Eldrup E
BMJ case reports 2021; (14(6)) doi:10.1136/bcr-2021-243191.
PMID: 34144953
15
Mycetoma management and clinical outcomes: the Mycetoma Research Center experience.
Musa EA, Abdoon IH, Bakhiet SM, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2023; (117(1)):12-21 doi:10.1093/trstmh/trac069.
PMID: 35903002
16
Interpretable machine-learning prognosis of mycetoma from routine clinical data.
Yousif MH, Alsammani A, Abdalla MH, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2026; (120(9)):929-947 doi:10.1093/trstmh/trag061.
PMID: 42206479
17
Global sociodemographic, clinical, and epidemiological profiling of patients with mycetoma: A systematic review.
Salah ME, Fearon Scales ML, Habib K, et al.
PLoS neglected tropical diseases 2025; (19(8)):e0013217 doi:10.1371/journal.pntd.0013217.
PMID: 40811735

This page explains mycetoma treatment and monitoring for informational purposes only and does not constitute medical advice. Follow an individualized plan from your treating clinician and report side effects promptly.

Guide Contents